Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.00105
+0.000015 (1.45%)
At close: Jun 16, 2026
Halberd Market Cap
Halberd has a market cap or net worth of $784.67 thousand as of June 16, 2026. Its market cap has decreased by -43.39% in one year.
Market Cap
784.67K
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 784.67K, a decrease of -69.89%. That is a compound annual growth rate of -6.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 784.67K | -26.04% |
| Dec 31, 2025 | 1.06M | -58.29% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyra Therapeutics | 1.15M |
| Burzynski Research Institute | 1.12M |
| Avenue Therapeutics | 1.05M |
| Evofem Biosciences | 996.63K |
| Agentix | 841.41K |
| Emmaus Life Sciences | 722.94K |
| Windtree Therapeutics | 719.81K |
| Protagenic Therapeutics | 716.84K |